Approval · Notice of Compliance 4008 · 1997

AREDIA: Notice of Compliance 4008

Issued June 20, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 4008
Date: June 20, 1997
Company: Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Bone metabolism regulator

Products in this notice

Brand	DIN	Status today
AREDIA	02059762	Cancelled Post Market
AREDIA	02059770	Cancelled Post Market
AREDIA	02059789	Cancelled Post Market

Medicinal ingredients

PAMIDRONATE DISODIUM 30 MG per VIAL
PAMIDRONATE DISODIUM 60 MG per VIAL
PAMIDRONATE DISODIUM 90 MG per VIAL